| Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains C Carpenito, MC Milone, R Hassan, JC Simonet, M Lakhal, MM Suhoski, ... Proceedings of the National Academy of Sciences 106 (9), 3360-3365, 2009 | 954 | 2009 |
| Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor A Varela-Rohena, PE Molloy, SM Dunn, Y Li, MM Suhoski, RG Carroll, ... Nature medicine 14 (12), 1390-1395, 2008 | 292 | 2008 |
| Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules MM Suhoski, TN Golovina, NA Aqui, VC Tai, A Varela-Rohena, ... Molecular Therapy 15 (5), 981-988, 2007 | 287 | 2007 |
| The inducible costimulator (ICOS) is critical for the development of human TH17 cells CM Paulos, C Carpenito, G Plesa, MM Suhoski, A Varela-Rohena, ... Science translational medicine 2 (55), 55ra78-55ra78, 2010 | 276 | 2010 |
| 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy H Zhang, KM Snyder, MM Suhoski, MV Maus, V Kapoor, CH June, ... The Journal of Immunology 179 (7), 4910-4918, 2007 | 253 | 2007 |
| CD28 costimulation is essential for human T regulatory expansion and function TN Golovina, T Mikheeva, MM Suhoski, NA Aqui, VC Tai, X Shan, R Liu, ... The Journal of Immunology 181 (4), 2855-2868, 2008 | 200 | 2008 |
| Artificial antigen presenting cells and uses therefor JL Riley, CH June, RH Vonderheide, N Aqui, MM Suhoski US Patent 7,754,482, 2010 | 193 | 2010 |
| Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen … KL Hippen, P Harker-Murray, SB Porter, SC Merkel, A Londer, DK Taylor, ... Blood, The Journal of the American Society of Hematology 112 (7), 2847-2857, 2008 | 155 | 2008 |
| Cdc42-interacting protein–4 functionally links actin and microtubule networks at the cytolytic NK cell immunological synapse PP Banerjee, R Pandey, R Zheng, MM Suhoski, L Monaco-Shawver, ... The Journal of experimental medicine 204 (10), 2305-2320, 2007 | 140 | 2007 |
| Retroviral and lentiviral safety analysis of gene-modified T cell products and infused HIV and oncology patients KT Marcucci, JK Jadlowsky, WT Hwang, M Suhoski-Davis, VE Gonzalez, ... Molecular therapy 26 (1), 269-279, 2018 | 105 | 2018 |
| IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells SJAM Santegoets, AW Turksma, MM Suhoski, AGM Stam, SM Albelda, ... Journal of translational medicine 11 (1), 1-10, 2013 | 84 | 2013 |
| Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines IS Junttila, RJ Creusot, I Moraga, DL Bates, MT Wong, MN Alonso, ... Nature chemical biology 8 (12), 990-998, 2012 | 81 | 2012 |
| Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes Q Ye, M Loisiou, BL Levine, MM Suhoski, JL Riley, CH June, G Coukos, ... Journal of translational medicine 9 (1), 1-13, 2011 | 76 | 2011 |
| TH1, TH2, and TH17 cells instruct monocytes to differentiate into specialized dendritic cell subsets MN Alonso, MT Wong, AL Zhang, D Winer, MM Suhoski, LL Tolentino, ... Blood, The Journal of the American Society of Hematology 118 (12), 3311-3320, 2011 | 68 | 2011 |
| Artificial antigen presenting cells and uses thereof JL Riley, CH June, RH Vonderheide, N Aqui, MM Davis US Patent 9,555,105, 2017 | 67 | 2017 |
| Nonviral RNA chimeric antigen receptor–modified T cells in patients with Hodgkin lymphoma J Svoboda, SR Rheingold, SI Gill, SA Grupp, SF Lacey, I Kulikovskaya, ... Blood, The Journal of the American Society of Hematology 132 (10), 1022-1026, 2018 | 53 | 2018 |
| Adoptive immunotherapy: good habits instilled at youth have long-term benefits CM Paulos, MM Suhoski, G Plesa, T Jiang, S Basu, TN Golovina, S Jiang, ... Immunologic research 42, 182-196, 2008 | 53 | 2008 |
| Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency I Moraga, D Richter, S Wilmes, H Winkelmann, K Jude, C Thomas, ... Science signaling 8 (402), ra114-ra114, 2015 | 52 | 2015 |
| Artificial antigen presenting cells and uses therefor JL Riley, CH June, RH Vonderheide, N Aqui, MM Suhoski US Patent 8,722,400, 2014 | 44 | 2014 |
| Pilot study of anti-CD19 chimeric antigen receptor T cells (CTL019) in conjunction with salvage autologous stem cell transplantation for advanced multiple myeloma AL Garfall, EA Stadtmauer, MV Maus, WT Hwang, DT Vogl, AD Cohen, ... Blood 128 (22), 974, 2016 | 36 | 2016 |
